Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So this is the facility?
Forgive me if this has been asked and answered already. Looking at Labwire's address on Google satellite it appears to be a "farm" of some sort. Does Labwire do their own testing or do they contract it out. If inhouse is it done at the address listed on there website and the ibox here? Thanks for any help!
Any luck remembering who you spoke with? tia
Someone at Magnum this morning, Did the someone have a name?
Did you just call 305-420-6563 ?
Seems strange someone not affiliated with MDOR would shell out $44k . Unless they had a lot of shares to move. I'll try calling right now- see if I can get any further.
Brass Bulls was the firm PBLS hired as an IR firm right before the share dumpathon began there. I'd be looking for plenty more shares hitting the market as soon as EXPH's PR "campaign" comences.
Classic--
Free-Press-Release.com has been the No. 1 in the free press release distribution service area since 2003. Thousands of media editors, broadcasters, press journalists and freelancers come to this site for fresh news stories everyday. Any business can benefit from the potential media coverage generated from a well-structured press release. With the help of Free-Press-Release.com, your release will be sent directly to thousands of important members of the media community without the high costs of hiring a PR agency.
http://www.free-press-release.com/cat/248-4.html
http://www.free-press-release.com/news/200829/1222745790.html
Best "GREEN" stock in the market...> MDOR.OB (131mm in Contracts but yet cheap at 9mm mkt cap)
NEWS OUT TODAY!!!! Magnum Completes $1 Million Schedule D Conventional Funding Subscription and...
Posted by jon (September 29, 2008) [posted by jon?]
http://www.free-press-release.com/how-to-press-release/choice.
http://www.free-press-release.com/release-features.html
Gotta be worth at least $44,000.....
Joel probally forgot to mention how bullish he was about oil during his presentation?
Thanks - only blog I can find of his about bank stocks is from May 08- calling for C to go to $16, Did he have others?
Thanks for your thoughts-
First I posted this on the C board-
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=34764438
So I understand that theory ...
But you posted an article that actually wasn't saying the shareholders would be wiped-out- but emphasized that part. As far as the Joe stocks AJ exchange - [ two great minds/posters] I read it that Joe disagrees that BAC and C are worthless.
And I also wrote this on the BAC board
" That said- I can easily see all the financials dropping lower and staying low and dividend-less for several years". I wrote this b4 they dropped the divi.
But there is a big difference in Wipeing-out the shareholders and price dropping further or several years of dead money.
The main point for me is that if BAC would somehow "wipe-out" the common, how do you think the market as a whole would react? I mean the whole market [ in it's ponzi scheme glory] is probably still over valued- but at what point do we say- enough- Either the US stock market will survive and again flourish or game over for life as we know it?
Any luck with Nostradamus's name and Blogs?
"The move would fall short of what the government did two decades ago,"
I'm not sure why you are highlighting "wipeing out shareholders" ?
If BAC/Gov wipes out the common-
DOW 2000 here we come.
BTW never happen- imo
Nice, notice they were compensated -
MCM was compensated $44,000 USD for a 3 month investor relations contract for select service times during 2008 to Magnum D'Or Resources.
http://www.microcapmedia.com/disclaimer.html
Can you point me to his name and his blogs?
Tentatively for 6:00pm est
http://finance.aol.com/event/axcelis-technologies-inc/acls/nas
Evercore added over 460,000 shares as of 1/22/09. Hope they know something we don't.
http://www.mffais.com/acls.html
They have a CC on Monday- will tell alot. Someone still buying big blocks at 4:00pm every day but also someone ['s] been dumping too. I'm still holding- believing that Sumitomo will make some kinda deal b4 letting the assets get pieced out during a BK.
I'm saying it won't fail- and getting more money now is likely to be a real positive for Friday- assuming BAC doesn't have Hindenburg type news.
I'm with ya on the 7am gulp. BAC is in 50% of American households in one form or another- If bank of America should fail, I'm thinking that the entire market goes with it- I mean who would ever invest again in any financial institution if BAC [ with the goverment's full support] failed ? That said- I can easily see all the financials dropping lower and staying low and dividend-less for several years. But, luckily we have a huge short position here and they can really move the stock when they feel like covering.
I'm sure I'll be up early, looking for any hint ...
Good luck!
Normally moving the earnings release up and pre=market is portending good news- In this case I'm thinking it could be bad news [mostly priced in?]. Figuring if it's bad news the market would have a 3 day weekend to digest it and then the Inauguration to take a little focus off the results on Tuesday- But for that theory to be likely I'd think BAC would release after the market on Friday in order to maybe minimize PPS damage. SOOooooo I bought 3k at an average of $7.62/shr, with designs on averaging down if pre-market news is bad [worse than the market expects] or holding my shares for a mini Obama rally.
How's that for convoluted reasoning?
Bank America moved up it's earnings release to Friday [ Tommorrow] at 7am est. Hmmmmm.
From Tuesday- Could be a major rally with Citi- or a new bottom in financials.,,
I guess management thinks they can play hardball and renegotiate the loan for better terms. Not sure if that's a great idea. Notice someone trying to bail afterhours in the mid .40s.
Pass the Maalox
http://biz.yahoo.com/pz/090115/157790.html
Hopefully we'll have good news this weekend.
Likely a bouncer- especially if Smurfit sees fit to pr the sitiuation.
Saw that Wed, afternoon- shoulda clued me in when I read it- said they paid the bonuses in cash- something about not enough stock....
Payment of the MIP awards for 2008 was made entirely in cash. The MIP was amended to provide for the all-cash payout because there were an insufficient number of shares available under the plan to pay a portion of the awards in Restricted Stock Units (RSUs"), as provided in the plan. The amendment also eliminated the Company premium that had previously been awarded in the form of RSUs representing 20% of the portion of the executive's MIP award which, prior to the amendment, would have been required to be deferred into RSUs.
Hmmm they need to pay 7 million this week - wonder why they broke the piggy bank for the execs instead?
In the swamp ofcourse- actually just hopping from stock to stock,, How about you? Still minding the Confessional?
I was able to get 15k at .20 after hours through Schwab- may go lower but this seems like a ploy to refinance their debt. This company looks to be worth much more than .17 liquidation value. But who knows in this market- will certainly be watching this week and next.
Holding company Smurfit-Stone Container doesn't think outside the box -- it thinks about the box. Its operating company, Smurfit-Stone Container Enterprises, makes corrugated containers, containerboard, kraft paper (for bags), market pulp, and solid bleached sulfate (SBS, for folding cartons); it also provides graphics services. The vertically integrated company is one of the world's largest recyclers of paper fiber, a key raw material in the making of the company's products. Smurfit-Stone buys the bulk of its wood fiber on the open market, but it also owns about a million acres of timberland in Canada and operates harvesting facilities in the US and Canada.
Christopher Whalen said the evening after Citi was "bailed out" That the common is now worthless- he said that the goverment was now the owner of Citi - not an investor. This was about a month ago- he speculated that Citi would be broken up and sold off- might be right.
Interesting
If Morgan Stanley ends up buying Smith Barney, it "sounds like the beginning of a liquidation," said Christopher Whalen, managing director of Institutional Risk Analytics.
Citigroup, Morgan Stanley To Consolidate
Banks (And Bailout Recipients) Close To $2 Billion Deal To Combine Brokerage Businesses
Citigroup is likely to get $2 billiion to $3 billion from Morgan Stanley for a 51 percent stake in Citi's brokerage arm Smith Barney. (AP / file
Stories
Questions, Doubts Loom Over Bailout Money
2 Major Bank Buyouts Completed
(AP) A deal to combine the brokerages of Citigroup and Morgan Stanley - which would give Citi more cash, and Morgan Stanley more manpower - appears just days away.
Morgan Stanley is likely to pay Citigroup between $2 billion to $3 billion for a 51 percent stake in the brokerage Smith Barney, a person close to the negotiations said.
Morgan Stanley would then have the option to buy Smith Barney over the next three to five years, the person said. The person spoke on condition of anonymity because he was not authorized to speak about the ongoing talks.
If negotiations proceed through the weekend as they have been, an announcement could come as early as Monday, the person said.
Word of the negotiations came as investors digested news Friday that Robert Rubin, a senior adviser to Citi who has drawn heavy criticism, would resign and would not seek another term on the board.
A combination of the brokerage units would help Citigroup get more much-needed cash and cut costs, said Aite Group analyst Alois Pirker. The benefit for Morgan Stanley, Pirker said, would be a bigger staff to compete with other growing brokerages - particularly Merrill Lynch, which recently was acquired by Bank of America Corp..
The deal may also lead to a full-fledged merger between the two banks, he speculated.
"The ultimate goal could be to merge the two entities fully," Pirker said. "Morgan Stanley needs deposits, there's no doubt about that. They won't get that by telling brokers to get deposits from their clients."
Morgan Stanley applied to become a bank holding company last fall to get loans from the government and collect deposits - one of the few reliable sources of funding these days with the credit markets still squeezed.
The government is not driving the negotiations between Citigroup and Morgan Stanley, people with knowledge of the situation said. They also spoke on condition of anonymity because they were not authorized to speak about the matter.
There were no talks scheduled for this weekend between the Treasury Department and Citigroup officials.
The potential deal is another sign of the U.S. banking industry's consolidation into a few huge power players - ones that are still heavily reliant on the government for backing as the economy deteriorates.
"It's a bit of a worrying sign, I think," Pirker said. "It seems like the firms are too big as they are, from the brokerage perspective. They are racing to get bigger than the next one. One wonders if they'll have to shrink back again."
Morgan Stanley is one of the few remaining Wall Street firms after the credit crisis last year sent Lehman Brothers Holdings Inc. into bankruptcy and Merrill to Bank of America.
Citigroup's CEO Vikram Pandit spent decades working at Morgan Stanley before starting his own hedge fund, and has appointed many former colleagues to top-level management positions at Citigroup.
Private analysts said Citi's interest in raising revenue with a Smith Barney deal was likely aimed at demonstrating to the government and Wall Street investors that it was working to bolster Citi's finances.
The company has reported four straight quarters of losses totaling $20.2 billion through September 2008 and is expected to post yet another loss when it releases fourth-quarter results on Jan. 22. Thomson Reuters said analysts it surveyed expect Citi to report a loss, on average, of $1.14 a share for the October-December period.
Citigroup has received $45 billion in support from the government's $700 billion financial rescue fund, an amount that is almost double what has been provided to any other major bank.
Some analysts said that they expected Citi to make further efforts beyond Smith Barney to sell assets to raise cash including selling some of their foreign operations.
"The bottom line is that Citigroup has to shrink its size and sell off assets to bring in cash to shore up their capital base and be in a better position to eventually pay back the government," said Sung Won Sohn, an economist at the Smith School of Business at California State University.
"Even during the boom times, Citi was in too many businesses," Sohn said. "I think Citigroup is going back to what it used to be, a much smaller organization with significantly reduced costs."
Citigroup was hit particularly hard by the housing market downturn because the bank was heavily invested in mortgages and other loans. The company has reported four straight quarters of losses, and is expected to post yet another loss when it releases fourth-quarter results later this month.
If Morgan Stanley ends up buying Smith Barney, it "sounds like the beginning of a liquidation," said Christopher Whalen, managing director of Institutional Risk Analytics.
© MMIX The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.
Wow, things are heating up-- check the news!
Yahoo!My Yahoo!Mail Make Y! your home pageYahoo! SearchSearch:Sign In
New User? Sign UpFinance Home -Help
Home InvestingMarket OverviewMarket StatsStocksMutual FundsETFsBondsOptionsIndustriesCurrencies New!EducationNews & OpinionMarketsInvesting IdeasExpert AdviceSpecial EditionsCompany FinancesProvidersPersonal FinanceBanking & BudgetingCareer & WorkCollege & EducationFamily & HomeInsuranceLoansReal EstateRetirementTaxesHow-to GuidesTech Ticker Get QuotesFinance Search 7811758
Press Release Source: Biotechnology Value Fund, L.P.
Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees
Friday January 9, 1:21 pm ET
Calls Special Meeting to Enable Stockholders to Determine Fate of Company's Remaining Cash
Believes Transaction Proposed by MediciNova, Inc. Offers Avigen Stockholders Extraordinary Risk/Reward Opportunity
ADVERTISEMENT
SAN FRANCISCO, Jan. 9 /PRNewswire/ -- Biotechnology Value Fund, L.P. together with its affiliates ("BVF") today announced that it has requested that the Board of Directors of Avigen, Inc. ("Avigen") (Nasdaq: AVGN - News) call a Special Meeting of the stockholders for the purpose of replacing the Board with BVF's slate of stockholder focused nominees. BVF is the beneficial owner of approximately 29.6% of Avigen's outstanding common stock.
BVF proposes to remove the members of the Board and replace them with directors who will work to ensure Avigen's stockholders receive the maximum value for their investment in Avigen, while minimizing both downside risk and corporate waste. If elected, BVF's nominees intend to take steps that would benefit all stockholders, including redeeming Avigen's stockholder rights plan, working to consummate the proposed transaction with MediciNova, Inc. ("MediciNova") and/or working to complete a distribution of Avigen's assets to all stockholders.
BVF has nominated four highly qualified nominees, Mark N. Lampert, Oleg Nodelman, Matthew D. Perry and Robert M. Coppedge, as its slate of director nominees to be elected at the Special Meeting to replace Avigen's entire existing Board. Messrs. Lampert, Perry, and Nodelman are currently employed by the General Partner of BVF. Mr. Coppedge is an independent nominee, with no economic interest in BVF, Avigen, or MediciNova. Avigen's bylaws provide that the Board shall set the date of the Special Meeting, which shall be held not less than thirty-five (35) nor more than one hundred twenty (120) days after the date of receipt of BVF's request. The bylaws further provide that if the Board does not provide notice of the Special Meeting within sixty (60) days following receipt of the request, BVF may set the time and place of the meeting and give the notice.
"We are deeply concerned with recent corporate actions at Avigen that are indicative of a Board that seems far more interested in remaining in place to do whatever it pleases with corporate assets than in returning value and protecting downside risk for all stockholders," stated Mark N. Lampert, the General Partner of BVF. "Given that Avigen's stock trades at a fraction of its tangible assets, it appears the marketplace shares our concerns. Accordingly, by calling the Special Meeting, we are providing stockholders with the opportunity to elect new directors who are committed to ensuring that Avigen stockholders, not an entrenched and unsuccessful management team and Board, determine the fate of the substantial remaining value."
Mr. Lampert continued, "In addition to the Board's unilateral expansion of 'golden parachute' payments for management and its unilateral adoption of the 'poison pill,' we are also concerned with the Board's apparent dismissal of the compelling transaction proposed by MediciNova. Based on our analysis, we believe the transaction, as proposed, provides benefits to stockholders that the Board and management could not match on its own. In particular, we believe this deal would provide Avigen stockholders with:
Downside Protection: Based on our analysis, subsequent to the transaction, if MediciNova is unsuccessful Avigen stockholders will receive a modest discount to the current liquidation value of Avigen (which we estimate to be approximately $1.20/Share, net of debt and expenses), as determined by an independent auditor. This means that, even in the worst-case scenario, this transaction would yield an approximate 40% premium to Avigen's current stock price.
Tremendous Upside Potential: Based on our analysis, if MediciNova is successful post-transaction, Avigen stockholders could own a substantial percentage of MediciNova - approximately 45% of the combined company. Under the best-case scenario, this could lead to an extraordinary, uncapped return for Avigen stockholders.
Free Option: Additionally, stockholders would have at least one year following consummation of the transaction to choose whether they want the downside protection or upside potential, as described above. We believe this free option period offers stockholders tremendous upside potential with low risk.
New Stewardship of Avigen's Assets: If successfully completed, the transaction would also result in new stewardship of Avigen's assets, curtailing this Board's and management's stated plan of seeking ways to utilize and, we fear, waste Avigen's remaining assets. We believe stockholder focused management, with a substantial personal stake in the company, is key to protecting Avigen's assets, particularly in light of Chief Executive Officer Ken Chahine's recent statements regarding the future of Avigen, including that "it's hard to put a finger on exactly what we would do," that he "intends to build" over the next year and that he "thinks that there are opportunities outside of therapeutics."
Unique Synergies: We also strongly believe there are unique synergies between MediciNova and Avigen that likely would not exist with other potential acquirers of Avigen. These synergies, we believe, give rise to the compelling nature of the transaction."
Mr. Lampert added, "For these reasons, we believe Avigen should seriously pursue the transaction with MediciNova, a company in which we have no economic stake. We are extremely concerned that this Board and management, who collectively own less than 6% of Avigen, do not share our views. It is our hope that stockholders who share our concerns will be empowered to voice these concerns by removing the current Board and replacing them with directors who are serious about maximizing value and minimizing risk for all stockholders."
CERTAIN INFORMATION CONCERNING PARTICIPANTS
Biotechnology Value Fund, L.P. ("BVF"), together with the other participants named herein, intends to make a preliminary filing with the Securities and Exchange Commission ("SEC") of a proxy statement and accompanying proxy card to be used to solicit proxies for the removal of the members of the Board of Directors of Avigen, Inc. ("Avigen"), without cause, and for the election of BVF's slate of director nominees to replace the removed directors at a special meeting of stockholders, to be called by Avigen at the request of BVF and Biotechnology Value Fund II, L.P. ("BVF2").
BVF STRONGLY ADVISES ALL STOCKHOLDERS OF AVIGEN TO READ THE PROXY STATEMENT WHEN IT IS AVAILABLE BECAUSE IT WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY STATEMENT WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THE SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS' PROXY SOLICITOR.
The participants in the proxy solicitation are BVF, BVF2, BVF Investments, L.L.C. ("BVLLC"), Investment 10, L.L.C. ("ILL10"), BVF Partners L.P. ("Partners"), BVF Inc. ("BVF Inc."), Mark N. Lampert, Oleg Nodelman, Matthew D. Perry and Robert M. Coppedge.
As of the date of this filing, BVF beneficially owned 1,975,340 shares of Common Stock of Avigen, BVF2 beneficially owned 1,364,911 shares of Common Stock of Avigen, BVLLC beneficially owned 4,969,764 shares of Common Stock of Avigen and ILL10 beneficially owned 509,585 shares of Common Stock of Avigen.
As the general partner of BVF and BVF2, the manager of BVLLC and the investment adviser of ILL10, Partners may be deemed to beneficially own the 8,819,600 shares of Common Stock of Avigen beneficially owned in the aggregate by BVF, BVF2, BVLLC and ILL10. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the 8,819,600 shares of Common Stock of Avigen beneficially owned by Partners. Mr. Lampert, as a director and officer of BVF Inc. may be deemed to beneficially own the 8,819,600 shares of Common Stock of Avigen beneficially owned by BFV Inc.
None of Messrs. Nodelman, Perry or Coppedge directly owns any shares of Common Stock of Avigen. As a members of a "group" for the purposes of Rule 13d-5(b)(1) of the Securities Exchange Act of 1934, as amended, each of Messrs. Nodelman, Perry and Coppedge may be deemed to beneficially own the 8,819,600 shares of Common Stock of Avigen beneficially owned in the aggregate by the other participants named herein. Each of Messrs. Nodelman, Perry and Coppedge disclaims beneficial ownership of such shares of Common Stock.
Actually the spread is .85x1.00 . What you may be seeing is the bid/ask of market makers that are not yet open . CBOE is bidding .01 and asking $2.92 but they really aren't trying to make a market so to speak. At 8:00am est you'll see some other MM's open for pre-market trading and by 9:30 am est you'll get the current best bid/ask.
edit .75x1.00
errr .92x1.00
Yep, into the wall, then staggered backwards today.
I now own 100k shares at an average of .52. I'll be keeping my mouth shut until we get the Sumitomo buyout offer at $3.00/shr- then I may get a little crazy. Good luck- and remember the insider buys!
Ever heard of Chad Curtis?
And here we go...right into the wall or through it this time?
They definately have the Ginsu knives out today... .6876x.6894
They have to let this go...
Looking for a break of .78 today .
mocked by the mockers ?
Kinda like being smucked by smuckers?
Someone's converting their Christmas coal into CAML shares today.
Looks like the offer would not satisfy the "liquidate" the company crowd, but in a reasonable market we should be around $1.50/shr. I'm thinking there is/will be other suitors . The offer makes my brain hurt so I asked a buddy at to translate.I'll Let everyone know if I get any answer.